Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
AM-111 0.8 mg/ml
DRUG
2 trials
Sponsors
Auris Medical AG
, Auris Medical, Inc.
Conditions
Hearing Loss
Hearing Loss, Idiopathic Sudden Sensorineural
Phase 3
AM-111 in the Treatment of Acute Inner Ear Hearing Loss
Completed
NCT02561091
Auris Medical AG
Hearing Loss
Start: 2015-11-30
End: 2017-09-30
Updated: 2023-09-14
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Terminated
NCT02809118
Auris Medical, Inc.
Hearing Loss, Idiopathic Sudden Sensorineural
Start: 2016-06-30
End: 2018-02-28
Updated: 2020-08-07